Impact of Elexacaftor/Tezacaftor/Ivacaftor on Cystic Fibrosis Liver Tests in a Real-World Cohort with and Without Baseline CFLD

被引：0
|
作者：
Bowen, M. [1 ]
Sample, E. [1 ]
Collins, A. [1 ]
Singhal, A. [1 ]
Brown, A. [1 ]
机构：
[1] Inova Fairfax Hosp, Adv Lung Dis & Lung Transplant, Falls Church, VA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2028
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world effectiveness of elexacaftor/tezacaftor/ivacaftor on the burden of illness in adolescents and adults with cystic fibrosis
    Keens, Thomas
    Hoffman, Veena
    Topuria, Ia
    Elder, Ken
    Cerf, Shannon
    Mulder, Kyra
    Roberts, Jon
    Lysinger, Jerimiah
    Del Carmen Reyes, Maria
    Berdella, Maria
    Cairns, Anne Marie
    Jain, Manu
    Ganapathy, Vaidyanathan
    Lou, Yiyue
    Morcos, Bassem
    Wu, Chuntao
    Sass, Laura
    HELIYON, 2024, 10 (07)
  • [2] Real-world impact of Elexacaftor-Tezacaftor-Ivacaftor treatment in young people with Cystic Fibrosis: A longitudinal study
    Connett, Gj
    Maguire, S.
    Larcombe, Tc
    Scanlan, N.
    Shinde, Ss
    Muthukumarana, T.
    Bevan, A.
    Keogh, Rh
    Legg, Jp
    RESPIRATORY MEDICINE, 2025, 236
  • [3] Real-World Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Triple Combination Therapy in Pediatric Patients with Cystic Fibrosis
    Nazzari, E.
    Russo, M.
    Faelli, N.
    Rosazza, C.
    Bricchi, S.
    Rizza, C.
    Alicandro, G.
    Dacco, V
    PEDIATRIC PULMONOLOGY, 2023, 58 : S115 - S115
  • [4] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [5] Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis
    Lonabaugh, Kevin
    Li, Galvin
    List, Rhonda
    Huang, Reyna
    James, Amber
    Barros, Andrew
    Somerville, Lindsay
    Albon, Dana
    PHARMACOTHERAPY, 2024, 44 (03): : 231 - 240
  • [6] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [7] The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis
    Granados, Andrea L.
    Chan, Christine
    Moheet, Amir
    Vigers, Timothy
    Arbelaez, Ana Maria
    Larson Ode, Katie
    PEDIATRIC PULMONOLOGY, 2023, 58 (06) : 1805 - 1811
  • [8] EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS
    Portolese, Olivia
    Bilodeau, Marc
    Castel, Helene
    Willems, Bernard E.
    Huard, Genevieve
    Vincent, Catherine
    Lavoie, Annick
    Hercun, Julian
    HEPATOLOGY, 2023, 78 : S638 - S639
  • [9] Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
    Tewkesbury, Daniel H.
    Scott, Jennifer
    Barry, Peter J.
    Bright-Thomas, Rowland J.
    Hanley, Karen Piper
    Athwal, Varinder
    Jones, Andrew M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 349 - 353
  • [10] Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis
    McKinzie, Cameron J.
    Doligalski, Christina T.
    Lobritto, Steven J.
    Coakley, Raymond D.
    Gower, W. Adam
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : 227 - 229
12345